Greenberg Traurig Hosts the Launch of Healthcare Drinks’ Boston Chapter

Share Article

On Friday, September 9, 2016, Greenberg Traurig, LLP’s Boston office sponsored and hosted the launch of Healthcare Drinks’ Boston Chapter, which featured the timely discussion, “China-U.S. Cross Border Deal Making in Life Sciences.”

On Friday, September 9, 2016, Greenberg Traurig, LLP’s Boston office sponsored and hosted the launch of Healthcare Drinks’ Boston Chapter, which featured the timely discussion, “China-U.S. Cross Border Deal Making in Life Sciences.”

Dr. Fang Xie, co-leader of Greenberg Traurig’s Biotechnology and Pharmaceutical Industry Group of the global Life Sciences & Medical Technology Group, moderated the panel, which featured: Dr. John Lu, President and CEO of Vcanbio Centre for Translational Biotechnology; Dr. Wei Li, Founding Partner of WuXi Healthcare Ventures; and Mark Charest, Ph.D., Portfolio Manager, Phenomic Capital. Topics included an overview of representative types of cross-border deals, the deal-making process, recent trends in life sciences deals, and challenges and opportunities in U.S.-China cross-border transactions. The panel discussion was followed by a networking reception attended by local biotech executives and investors.

Healthcare Drinks provides a platform for all sectors of management in the health care industry to meet, exchange ideas and socialize in a casual yet professional, educational and supportive atmosphere. Its members include executives from medical device, pharmaceutical, biotech, hospitals and e-health firms, as well as doctors and management from hospitals and clinics. Healthcare Drinks has chapters in Beijing, Hong Kong, Melbourne, San Francisco, Shanghai, Shenzhen, Taipei, Twin Cities and most recently, Boston.

About Greenberg Traurig’s Life Sciences & Medical Technology Group

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. As part of the group, the Biotechnology and Pharmaceutical Industry Group focuses on advising clients in the biotechnology and pharmaceutical sectors.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2,000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No. 1 on the 2015 Law360 Most Charitable Firms list, second largest in the U.S. on the 2016 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website